Jonathan Zalevsky
Nektar Therapeutics (United States)
ORCID: 0000-0003-2707-1709MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab”.
9 citations
Naina Singhi, Brenda L. Jesernig, Kelly G. Paulson, Jonathan Zalevsky, Ernesto Iacucci +3 more
95 citations
Justin D. Saco, Felix B. Salazar, Jennifer Tsoi, Paige Krystofinski, Cristina Puig-Saus +16 more